Tissue Reactions and Mechanism in Cardiovascular Diseases Induced by Radiation.
Xiao-Chang LiuPing-Kun ZhouPublished in: International journal of molecular sciences (2022)
The long-term survival rate of cancer patients has been increasing as a result of advances in treatments and precise medical management. The evidence has accumulated that the incidence and mortality of non-cancer diseases have increased along with the increase in survival time and long-term survival rate of cancer patients after radiotherapy. The risk of cardiovascular disease as a radiation late effect of tissue damage reactions is becoming a critical challenge and attracts great concern. Epidemiological research and clinical trials have clearly shown the close association between the development of cardiovascular disease in long-term cancer survivors and radiation exposure. Experimental biological data also strongly supports the above statement. Cardiovascular diseases can occur decades post-irradiation, and from initiation and development to illness, there is a complicated process, including direct and indirect damage of endothelial cells by radiation, acute vasculitis with neutrophil invasion, endothelial dysfunction, altered permeability, tissue reactions, capillary-like network loss, and activation of coagulator mechanisms, fibrosis, and atherosclerosis. We summarize the most recent literature on the tissue reactions and mechanisms that contribute to the development of radiation-induced cardiovascular diseases (RICVD) and provide biological knowledge for building preventative strategies.
Keyphrases
- cardiovascular disease
- radiation induced
- cardiovascular events
- endothelial cells
- clinical trial
- radiation therapy
- healthcare
- cardiovascular risk factors
- type diabetes
- early stage
- systematic review
- oxidative stress
- risk factors
- young adults
- squamous cell carcinoma
- locally advanced
- metabolic syndrome
- hepatitis b virus
- respiratory failure
- open label
- electronic health record
- phase iii
- squamous cell
- lymph node metastasis
- double blind
- placebo controlled